News
OrthoAccel® Technologies Introduces New AcceleDent Aura® to U.S. and Canadian Markets
May 6, 2013 10:20 am | by PR Newswire | CommentsHOUSTON, May 6, 2013 /PRNewswire/ -- Continuing to follow a remarkable path of innovation and growth, OrthoAccel® Technologies has announced the availability of their newest product, AcceleDent Aura, to orthodontic practices throughout the United States and Canada....
Portable Device Provides Rapid, Accurate Diagnosis
May 6, 2013 10:19 am | by Massachusetts General Hospital | CommentsA handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. The portable devices combines microfluidic technology with nuclear magnetic resonance (NMR) to not only diagnose these important infections but also determine the presence of antibiotic-resistant bacterial strains.
Medtronic Announces FDA Approval of New Portfolio Of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators
May 6, 2013 10:18 am | by Medtronic | CommentsMedtronic, Inc. has announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva® portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera® portfolio of implantable cardioverter-defibrillators (ICD).
AATS Report: Prospective Randomized On-X Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced Complications
May 6, 2013 9:00 am | by The Associated Press | CommentsMINNEAPOLIS--(BUSINESS WIRE)--May 6, 2013--On-X ® Life Technologies, Inc. (On-X LTI) announced today that interim results for the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) are being presented at the American Association for Thoracic Surgery Annual (AATS) meeting by John...
AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
May 6, 2013 9:00 am | by PR Newswire | CommentsBOSTON, May 6, 2013 /PRNewswire/ -- AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance...
Polycom Helps Healthcare Organizations Reduce Unnecessary Rehospitalizations, Supports Prevention and Wellness with New Video Collaboration Solutions for Robotics, Mobile Devices and Web Browsers
May 6, 2013 8:30 am | by The Associated Press | CommentsAUSTIN, Texas--(BUSINESS WIRE)--May 6, 2013--AMERICAN TELEMEDICINE ASSOCIATION CONFERENCE– Helping healthcare organizations improve medical care, and supporting prevention and wellness initiatives with HD video collaboration, Polycom, Inc. (Nasdaq: PLCM), the global leader in open, standards-based...
Hansen Medical to Exhibit Magellan Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France
May 6, 2013 8:03 am | by The Associated Press | CommentsHansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan Robotic System at the 8th Annual European Symposium of Vascular Biomaterials (ESVB) from Friday, May 10th to Monday, May 13th at the Strasbourg Hilton in...
Tactio Launches a Remote Patient Monitoring Mobile Health Solution to Control, Manage and Coach Type 1, Type 2, and Gestational Diabetes
May 6, 2013 8:00 am | by The Associated Press | CommentsAUSTIN, Texas--(BUSINESS WIRE)--May 6, 2013--Tactio Health Group announces the launch of TactioDiabetes, a diabetes-management tool that will help patients easily track several aspects of their lifestyle, including: TactioHealth App with TactioDiabetes Option tracking Type 1 Diabetes with Insulin...
Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer
May 6, 2013 7:00 am | by The Associated Press | CommentsOMAHA, Neb.--(BUSINESS WIRE)--May 6, 2013--Transgenomic, Inc. (OTCBB: TBIO) today announced that it has entered into a collaboration with Amgen Inc. (NASDAQ: AMGN) to develop a CE-IVD test to screen patients with metastatic colorectal cancer (mCRC) for RAS mutations ( KRAS and NRAS ). These RAS...
App Lets Amputees Program Their Own Bionic Hands
May 3, 2013 1:37 pm | by KATHY MATHESON - Associated Press | CommentsDouble-amputee Jason Koger used to fly hundreds of miles to visit a clinician when he wanted to adjust the grips on his bionic hands. Now, he's got an app. Koger came to Philadelphia this week to demonstrate the i-limb ultra revolution, a prosthetic developed by the British firm Touch Bionics....
Atrium Medical Announces 1-year results of the INFUSE-AMI Trial
May 3, 2013 1:00 pm | by PR Newswire | CommentsHUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the...
EarlySense System Implementation Shown to Reduce Falls, Decrease Transfers to Hospitals and Increase the Quality of Care for Elderly in Multi-Center Nursing Home Study
May 3, 2013 1:00 pm | by PR Newswire | CommentsWALTHAM, Massachusetts, May 3, 2013 /PRNewswire/ -- EarlySense, the market leader in Proactive Patient Care Solutions™, announced today the results of a multi-center clinical study demonstrating that the EarlySense system helps medical teams at rehabilitation centers to reduce...
Researchers Determine Where Best to Place Defibrillators
May 3, 2013 9:55 am | by University of Toronto Faculty of Applied Science & Engineering | CommentsPrompt use of an automated external defibrillator, or AED, can greatly increase the survival rates of people who suffer a cardiac arrest. And MIE Professor Tim Chan, working with Dr. Laurie Morrison at St. Michael's Hospital, has developed a formula to determine where best to place these costly but life-saving devices.
Turning Human Stem Cells into Brain Cells Sheds Light on Neural Development
May 3, 2013 9:52 am | by Children's Hospital of Philadelphia | CommentsMedical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism. The new model cell system allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.
St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study
May 3, 2013 9:46 am | by Business Wire | CommentsSt. Jude Medical, a global medical device company, today announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) and Quartet lead to assess pacing in multiple locations in the heart.
